Clinical Research Hub
Live Research Database

Diabetes
Hub: San Antonio, TX

Connecting patients in San Antonio with breakthrough clinical trials, specialized care, and study-related compensation.

User
User
User
User
+4k
Join 4,200+ participants tracking trials in Texas

Available Diabetes Opportunities

14 Recruiting
NCT07053293(Verify)

SGLT2i, Hepatic Glucose Production, and SNS

RECRUITING
Diabetes
NCT07321886(Verify)

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

RECRUITING
Diabetes
NCT06446531(Verify)

Prevention of Progression of Prediabetes, Obesity and CV Risk

RECRUITING
Diabetes
NCT06783309(Verify)

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

RECRUITING
Diabetes
NCT06108076(Verify)

Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

RECRUITING
Diabetes
NCT06246799(Verify)

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

RECRUITING
Diabetes
NCT07024823(Verify)

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

RECRUITING
Diabetes
NCT05057806(Verify)

SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan

RECRUITING
Diabetes
NCT07502508(Verify)

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

RECRUITING
Diabetes
NCT06466135(Verify)

Study of WAL0921 in Patients With Glomerular Kidney Diseases

RECRUITING
Diabetes
NCT06598241(Verify)

Mirragen Diabetic Foot Ulcer Study

RECRUITING
Diabetes
NCT06717698(Verify)

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

RECRUITING
Diabetes
NCT07282600(Verify)

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RECRUITING
Diabetes
NCT07284979(Verify)

Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

RECRUITING
Diabetes

Patient Safeguards

IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks

"Advancing Diabetes research in San Antonio through safe, transparent, and patient-first clinical trials."

ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT